Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
about
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesCannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responsesRestoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosisMonoacylglycerol lipase - a target for drug development?What we know and do not know about the cannabinoid receptor 2 (CB2)CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune DysregulationEndocannabinoid signaling in the etiology and treatment of major depressive illness.The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.Endocannabinoid signalling in innate and adaptive immunity.Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features.Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens.(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs.Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.Effects of Cannabinoids on T-cell Function and Resistance to Infection.Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditionsDronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10Current knowledge on cannabinoids in oral fluid.Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression.Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes.Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity.Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathwayTreatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Cannabinoids: well-suited candidates for the treatment of perinatal brain injury.Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome.Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophagesThe direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor.Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells.Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis.Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine.Street drug use during pregnancy: potential programming effects on preschool wheeze.
P2860
Q21093231-6BA3645F-E6B0-4F4A-96C0-83ED717000C8Q24623282-CF87C429-E235-42BB-9A82-3266CE46DE80Q24633610-A380D5CA-1A31-4F62-B961-6A2B4FC908BFQ26782048-C527F354-913A-4004-A281-5466C5C1AE07Q26998964-AF30740B-5157-4B80-8A13-8CC560841206Q27686851-DD85894E-B64A-4D66-9771-0374DE41CCE1Q28072822-5C28D4DF-1FD7-4A2A-B0A1-ACEB2049E31FQ30687668-277436CF-2C8C-49F7-BE1E-3AD1EF052627Q31122398-9A14C34E-3F92-42E4-981E-5758494B7168Q33908169-5E1870DF-C1B9-4280-A355-6717D6E81D2DQ34339177-352AA2FA-2E1F-4354-A8A6-2985D0633424Q34458059-EC085C82-088F-475C-86EB-C3F3FDA19865Q34642592-30514AF5-8B18-4477-8FC0-B2FC47CE9872Q34667539-AE76586F-1D55-47B4-9504-5ADC4A0F83A9Q34797382-4FFFB9AE-9404-4D61-ACC2-5FE40E46C09DQ34946743-5BF65DCE-6B27-461B-AAB9-78EE8BBF4BE1Q35672413-77047898-1BA2-4E33-A4F9-909CB2F53408Q35752103-52A50829-B582-43ED-9A57-C77E94F9C726Q35752185-AA208181-DE83-4D06-A3CD-DFBFFD672E8EQ35887816-A4A9F9BE-B172-4B89-BD87-47E2725C4902Q35896078-20709478-A156-435D-A535-BD8D54E81E64Q35927832-87B75BB8-5A20-46F4-8317-EA4C718026EBQ35940339-FF299D10-3E04-47C7-87DE-3605CA15D71BQ36370835-4B34B4E6-8173-4688-8572-D5368D8271A3Q36653071-CD3332B2-B6E9-45D4-838E-DE7D1ACF38D5Q36660540-BDCD338D-6D8D-42D9-8332-F7E315E442DBQ36832642-E5982FE6-E99E-4AEB-A5EC-FA418640ADFCQ37330515-CA4B3EF4-750F-4B59-93BD-9B3AEA7C90EFQ38220272-4FBD970D-5C93-450A-853E-CFFD922CA7DAQ38222889-1E12DA27-1DBE-48C0-BAAE-F90C1C06E7BEQ38324480-6F34DCA6-1B04-46F1-8DAD-94639776A537Q38543069-7EAF8196-1AFD-4599-80C9-D31A84CDB4C9Q38892140-F23689DF-DF6E-4BE0-A9FB-8D1EA345788FQ39000393-52B8B6C4-036E-47C8-8B00-5C7DC3B2F4F3Q39361876-62864586-DE61-4C43-9756-8EE87919584EQ39811791-19A25660-EEB1-4806-9F9D-0CA76D15534AQ41429518-8D138D7F-A786-4FD0-AE9B-DEB2DF609D15Q41738574-8743220E-4E66-46EC-8293-A56D825E4AACQ41956563-4DFBDA58-35B0-4A00-8E01-D62D9344BB84Q46278927-7DC5DD40-A7F5-4DD0-9695-36168F3B0838
P2860
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Unraveling the complexities of ...... gulation in health and disease
@ast
Unraveling the complexities of ...... gulation in health and disease
@en
Unraveling the complexities of cannabinoid receptor 2
@nl
type
label
Unraveling the complexities of ...... gulation in health and disease
@ast
Unraveling the complexities of ...... gulation in health and disease
@en
Unraveling the complexities of cannabinoid receptor 2
@nl
prefLabel
Unraveling the complexities of ...... gulation in health and disease
@ast
Unraveling the complexities of ...... gulation in health and disease
@en
Unraveling the complexities of cannabinoid receptor 2
@nl
P2860
P921
P1433
P1476
Unraveling the complexities of ...... gulation in health and disease
@en
P2093
Bonnie N Dittel
Sreemanti Basu
P2860
P2888
P356
10.1007/S12026-011-8210-5
P577
2011-10-01T00:00:00Z
P6179
1001001457